Microbot Medical Inc.MBOTNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-3.71%
↑ 84% above average
Average (39q)
-22.78%
Historical baseline
Range
High:682.07%
Low:-1493.22%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -3.71% |
| Q2 2025 | -23.24% |
| Q1 2025 | 11.92% |
| Q4 2024 | -3.94% |
| Q3 2024 | -31.42% |
| Q2 2024 | -5.33% |
| Q1 2024 | -15.28% |
| Q4 2023 | 18.71% |
| Q3 2023 | -9.47% |
| Q2 2023 | 20.38% |
| Q1 2023 | 4.86% |
| Q4 2022 | 11.69% |
| Q3 2022 | 2.50% |
| Q2 2022 | -12.19% |
| Q1 2022 | 19.33% |
| Q4 2021 | -54.27% |
| Q3 2021 | -3.07% |
| Q2 2021 | -3.51% |
| Q1 2021 | 8.95% |
| Q4 2020 | -8.78% |
| Q3 2020 | -28.18% |
| Q2 2020 | 12.90% |
| Q1 2020 | -8.80% |
| Q4 2019 | -11.00% |
| Q3 2019 | -15.92% |
| Q2 2019 | 19.36% |
| Q1 2019 | 8.06% |
| Q4 2018 | -18.88% |
| Q3 2018 | 7.35% |
| Q2 2018 | -24.88% |
| Q1 2018 | 1.43% |
| Q4 2017 | -24.45% |
| Q3 2017 | 2.14% |
| Q2 2017 | -2.35% |
| Q1 2017 | -111.27% |
| Q4 2016 | 682.07% |
| Q3 2016 | -1493.22% |
| Q2 2016 | 58.60% |
| Q1 2016 | 96.65% |
| Q4 2015 | 14.90% |